Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised EQT AB (publ) in connection with the listing on Nasdaq Stockholm (1)
Mandate

Vinge has advised EQT AB (publ) in connection with the listing on Nasdaq Stockholm

September 24, 2019 Capital Markets and Public M&A

Vinge has advised EQT AB (publ) (“EQT”) in connection with the offering and listing on Nasdaq Stockholm with first day of trading on 24 September 2019.

Vinge has advised EQT in connection with the listing and also with the connected reorganization. 


The Vinge team primarily consisted of Dain Hård Nevonen, Erik Sjöman, Sofie Bjärtun, Joel Wahlberg, Hampus Olsson, Joel Magnusson and Emelie Svanberg (Capital Markets), Christina Kokko, Filip Öhrner, Karl Klackenberg, Christian Brelin and Christina Odengran (M&A and Restructuring), Louise Brorsson Salomon, Josefine Larsson, Ludvig Wettergren and Pauline Lagerstrand (Banking and Finance), Mattias Schömer, Henrik Wastenson and Victor Ericsson (Tax), Marcus Glader and Emma Johansson (Competition and Regulatory) and Olof Jisland and Valter Gran (EQT Foundation).

Related

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025